Kairos Pharma announces 1-for-7 reverse stock split effective Sept. 1, 2026
Reuters2026/08/21 20:30- Kairos Pharma will execute a 1-for-7 reverse stock split, effective Sept. 1, 2026 at 12:01 a.m. ET.
- Shares will trade split-adjusted at the Sept. 1 market open on NYSE American under KAPA.
- Outstanding share count will fall, aiming to lift the per-share price to support NYSE American listing compliance.
- Convertible notes, warrants, equity awards will be proportionately adjusted to reflect the 1-for-7 ratio.
- Authorized share counts, par value, ownership percentages remain essentially unchanged, excluding minor rounding effects from fractional shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Extreme level of 8,500 emerges! Two top strategists raise S&P 500 target as strong earnings become key support
Despite facing a surge in US Treasury yields surpassing 5% and a slowdown in the AI sector, Wall Street institutions continue to raise their S&P 500 target prices, with the most bullish forecasts reaching up to 8,500 points.
BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences
LG Electronics Gains a Bull on Likely 3Q Earnings Beat -- Market Talk
2-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
